Core Insights - The Coca-Cola Company recorded a nearly $1 billion impairment on its Bodyarmor sports drink brand, impacting profits in Q4 of the previous year [1] - Operating income decreased by 32% in the same period, influenced by the impairment charge and currency headwinds [1] - The impairment was driven by revised future operating projections, a slowing long-term growth rate, increased competition, and focused innovation plans [2] Financial Performance - Coca-Cola's operating margin fell to 15.6% from 23.5% year-over-year due to the Bodyarmor charge [2] - Despite challenges, annual operating income grew by 38% in 2025, with an operating margin increase to 28.7% from 21.2% in 2024 [3] - North American operating income for Coca-Cola dropped 65% in Q4, partly due to the impairment charge [3] Historical Context - Coca-Cola previously recorded a $760 million impairment related to Bodyarmor two years ago, attributed to revised projections and higher discount rates due to macroeconomic changes [4] - The company acquired a 15% stake in Bodyarmor in 2018 and later purchased the remaining shares for $5.6 billion [4] Revenue Growth - In the last year, Coca-Cola's group net revenue increased by 2% to $47.9 billion, with organic growth of 5% [4] - For Q4 2025, reported revenue rose by 2%, and organic revenue grew by 5% to $11.8 billion, driven by a 4% increase in concentrate sales and a 1% rise in price/mix [5] Future Outlook - The company anticipates organic revenue growth of 4-5% and comparable profit growth of 7-8% for the current year [6] - Wall Street analysts project Coca-Cola's organic sales growth to be around 5% for the next year [6]